Login / Signup

Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.

Shuxin HuangChaofeng LiangYujie ZhaoTairan DengJiaxiong TanYuhong LuSichu LiuYangqiu LiShaohua Chen
Published in: Asia-Pacific journal of clinical oncology (2021)
Higher expression of TOX concurrent with PD-1, Tim-3, and CD244 in T cells from patients with B-NHL may contribute to T cell exhaustion and impair their special anti-tumor T cell activity. TOX may be considered a potential target for reversing T cell exhaustion and improving T cell function in hematological malignancies.
Keyphrases
  • poor prognosis
  • locally advanced
  • binding protein
  • squamous cell carcinoma
  • long non coding rna
  • nk cells
  • radiation therapy
  • risk assessment
  • climate change